Top Sell
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eagle Pharmaceuticals Inc | 0 | 1 | 0 | 0 | €3.46 | - | - |
| Salarius Pharmaceuticals Inc. | 0 | 1 | 0 | 0 | €0.41 | - | - |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.90 | €30.00 | 934.483% |
| Revance Therapeutics Inc. | 0 | 2 | 0 | 0 | €2.50 | - | - |
| Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.57 | €3.00 | 422.102% |
| Nymox Pharmaceutical Corp. | 0 | 2 | 0 | 0 | €0.23 | - | - |
| Karyopharm Therapeutics Inc. | 8 | 2 | 0 | 0 | €0.98 | €5.54 | 467.212% |
| Organovo Holdings Inc. | 0 | 7 | 0 | 0 | €0.92 | - | - |
| Minerva Neurosciences Inc. | 0 | 6 | 0 | 1 | €2.30 | - | - |
| Formycon AG | 3 | 1 | 0 | 0 | €43.85 | €100.00 | 128.050% |
| Promis Neurosciences Inc. | 0 | 1 | 0 | 0 | €1.47 | €1.20 | -18.367% |
| Neptune Wellness Solutions Inc | 0 | 13 | 0 | 0 | €0.14 | - | - |
| Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.77 | €3.00 | 69.731% |
| Trevena Inc. | 2 | 14 | 0 | 0 | €0.34 | €6.48 | 1814.919% |
| Chimerix Inc. | 3 | 1 | 0 | 0 | €0.86 | €5.51 | 538.264% |
| Biofrontera AG | 0 | 2 | 0 | 0 | €0.33 | €0.000 | -100.000% |
| Synthetic Biologics Inc. | 0 | 1 | 0 | 0 | €0.27 | - | - |
| Medigene AG | 1 | 2 | 0 | 0 | €1.18 | €1.00 | -14.894% |
| Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €10.40 | €22.00 | 111.538% |
| Palisade Bio Inc. | 3 | 1 | 0 | 0 | €0.34 | €21.06 | 6072.333% |
| Xenon Pharmaceuticals Inc. | 1 | 1 | 0 | 0 | €36.00 | €50.00 | 38.889% |
| Cytomx Therapeutics Inc | 1 | 1 | 0 | 0 | €1.63 | €50.00 | 2975.031% |
| Anavex Life Sciences Corp | 0 | 2 | 0 | 0 | €3.69 | - | - |
| Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €2.02 | - | - |
| Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |